Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating intravenous HNF4α srRNA in patients with advanced intrahepatic cholangiocarcinoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• HNF4α srRNA (HNF4α srRNA)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Intrahepatic Cholangiocarcinoma | EARLY_Phase 1 | Status: RECRUITING